| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |